← Back to Discover
PSP Research LLC
Period ended Sep 30, 2026 · Latest filing Oct 21, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Sep 30, 2026: $145,831,410
More quarters will appear as history becomes available.
Top holdings
Top 10 at Sep 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- ISHARES TR · 0-3 MTH TREASURY · 46436E718 · shares: $70,476,000
- SPDR SERIES TRUST · ST STR SP BIOT · 78464A870 · shares: $60,943,320
- SERA PROGNOSTICS INC · CLASS A COM · 81749D107 · shares: $5,009,072
- HALOZYME THERAPEUTICS INC · COM · 40637H109 · shares: $331,200
- MADRIGAL PHARMACEUTICALS INC · COM · 558868105 · shares: $302,376
- EXELIXIS INC · COM · 30161Q104 · shares: $292,050
- ROYALTY PHARMA PLC · SHS CLASS A · G7709Q104 · shares: $291,800
- ARGENX SE · SPONSORED ADR · 04016X101 · shares: $287,673
- NURIX THERAPEUTICS INC · COM · 67080M103 · shares: $284,520
- TG THERAPEUTICS INC · COM · 88322Q108 · shares: $278,900
Reported holdings
44 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| ISHARES TR | 0-3 MTH TREASURY | 46436E718 | — | 700,000 shares | $70,476,000 |
| SPDR SERIES TRUST | ST STR SP BIOT | 78464A870 | — | 386,500 shares | $60,943,320 |
| SERA PROGNOSTICS INC | CLASS A COM | 81749D107 | — | 2,396,685 shares | $5,009,072 |
| HALOZYME THERAPEUTICS INC | COM | 40637H109 | — | 3,000 shares | $331,200 |
| MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | — | 600 shares | $302,376 |
| EXELIXIS INC | COM | 30161Q104 | — | 5,000 shares | $292,050 |
| ROYALTY PHARMA PLC | SHS CLASS A | G7709Q104 | — | 5,000 shares | $291,800 |
| ARGENX SE | SPONSORED ADR | 04016X101 | — | 300 shares | $287,673 |
| NURIX THERAPEUTICS INC | COM | 67080M103 | — | 12,000 shares | $284,520 |
| TG THERAPEUTICS INC | COM | 88322Q108 | — | 5,000 shares | $278,900 |
| TARSUS PHARMACEUTICALS INC | COM | 87650L103 | — | 3,500 shares | $275,135 |
| HARMONY BIOSCIENCES HLDGS IN | COM | 413197104 | — | 7,000 shares | $274,820 |
| ARCUTIS BIOTHERAPEUTICS INC | COM | 03969K108 | — | 10,000 shares | $264,300 |
| KINIKSA PHARMACEUTICALS INTL | ORD SHS CL A | G52694109 | — | 3,500 shares | $261,135 |
| SUPERNUS PHARMACEUTICALS | COM | 868459108 | — | 6,000 shares | $258,240 |
| IMMUNOME INC | COM | 45257U108 | — | 12,000 shares | $258,120 |
| NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | — | 1,800 shares | $255,312 |
| ORUKA THERAPEUTICS INC | COM | 687604108 | — | 3,000 shares | $249,870 |
| TANGO THERAPEUTICS INC | COM | 87583X109 | — | 10,000 shares | $249,500 |
| DEFINIUM THERAPEUTICS INC | COM SHS | 24477V105 | — | 6,500 shares | $247,390 |
| REVOLUTION MEDICINES INC | COM | 76155X100 | — | 1,200 shares | $246,312 |
| ALKERMES PLC | SHS | G01767105 | — | 6,000 shares | $243,120 |
| AURINIA PHARMACEUTICALS INC | COM | 05156V102 | — | 15,000 shares | $242,925 |
| INCYTE CORP | COM | 45337C102 | — | 2,000 shares | $242,700 |
| INTELLIA THERAPEUTICS INC | COM | 45826J105 | — | 20,000 shares | $241,200 |
| IMMUNOVANT INC | COM | 45258J102 | — | 7,000 shares | $236,460 |
| STOKE THERAPEUTICS INC | COM | 86150R107 | — | 9,000 shares | $234,000 |
| KRYSTAL BIOTECH INC | COM | 501147102 | — | 692 shares | $230,132 |
| ASCENDIS PHARMA A/S | ORD SHS | K08588103 | — | 1,000 shares | $227,830 |
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | — | 12,000 shares | $225,600 |
| KYMERA THERAPEUTICS INC | COM | 501575104 | — | 2,000 shares | $223,580 |
| DIANTHUS THERAPEUTICS INC | COM | 252828108 | — | 2,500 shares | $220,125 |
| TREVI THERAPEUTICS INC | COM | 89532M101 | — | 15,000 shares | $214,800 |
| MIRUM PHARMACEUTICALS INC | COM | 604749101 | — | 2,500 shares | $213,700 |
| IMMUNOCORE HLDGS PLC | ADS | 45258D105 | — | 7,000 shares | $212,030 |
| PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | — | 1,500 shares | $211,335 |
| EDGEWISE THERAPEUTICS INC | COM | 28036F105 | — | 5,000 shares | $203,000 |
| ORIC PHARMACEUTICALS INC | COM | 68622P109 | — | 13,000 shares | $175,110 |
| DYNE THERAPEUTICS INC | COM | 26818M108 | — | 10,000 shares | $161,100 |
| COMPASS PATHWAYS PLC | SPONSORED ADS | 20451W101 | — | 10,000 shares | $124,400 |
| OCULAR THERAPEUTIX INC | COM | 67576A100 | — | 15,000 shares | $115,050 |
| CYTOMX THERAPEUTICS INC. | COM | 23284F105 | — | 39,400 shares | $107,168 |
| ARDELYX INC | COM | 039697107 | — | 30,000 shares | $102,600 |
| OLEMA PHARMACEUTICALS INC | COM | 68062P106 | — | 10,000 shares | $86,400 |